Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411.
Crane CH, Winter K, Regine WF, Safran H, Rich TA, Curran W, Wolff RA, Willett CG. Crane CH, et al. Among authors: rich ta. J Clin Oncol. 2009 Sep 1;27(25):4096-102. doi: 10.1200/JCO.2009.21.8529. Epub 2009 Jul 27. J Clin Oncol. 2009. PMID: 19636002 Free PMC article. Clinical Trial.
Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer Committee.
Willett C, Ajani J, Kelsen D, Sigurdson E, Abrams R, Berkey B, Benetz M, Crane C, Gaspar L, Goodyear MD, Gunderson L, Haddock M, Hoffmann J, Janjan N, John M, Kachnic L, Krieg R, Landry J, Meropol N, Minsky B, Mitchell E, Mohiuddin M, Moulder J, Myerson R, Noyes D, Pajak TF, Raben D, Regine W, Rich T, Robertson JM, Russell A, Skibber J, Kim P; Radiation Therapy Oncology Group. Willett C, et al. Int J Radiat Oncol Biol Phys. 2001;51(3 Suppl 2):19-27. Int J Radiat Oncol Biol Phys. 2001. PMID: 11641011 No abstract available.
Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials.
Willett CG, Safran H, Abrams RA, Regine WF, Rich TA; Gastrointestinal Committee of the Radiation Therapy Oncology Group. Willett CG, et al. Among authors: rich ta. Int J Radiat Oncol Biol Phys. 2003;56(4 Suppl):31-7. doi: 10.1016/s0360-3016(03)00446-2. Int J Radiat Oncol Biol Phys. 2003. PMID: 12826249 Review.
Postoperative adjuvant therapy for pancreatic cancer.
Penberthy DR, Rich TA, Adams RB. Penberthy DR, et al. Among authors: rich ta. Semin Surg Oncol. 2003;21(4):256-60. doi: 10.1002/ssu.10044. Semin Surg Oncol. 2003. PMID: 14648783 Review.
Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials.
Thomas CR Jr, Berkey BA, Minsky BD, Gaspar LE, Herskovic A, Rich TA, Gunderson LL. Thomas CR Jr, et al. Among authors: rich ta. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1405-10. doi: 10.1016/j.ijrobp.2003.09.022. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050316
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.
Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O'Connell MJ, Begovic M, Allmer C, Colangelo L, Smalley SR, Haller DG, Martenson JA, Mayer RJ, Rich TA, Ajani JA, MacDonald JS, Willett CG, Goldberg RM. Gunderson LL, et al. Among authors: rich ta. J Clin Oncol. 2004 May 15;22(10):1785-96. doi: 10.1200/JCO.2004.08.173. Epub 2004 Apr 5. J Clin Oncol. 2004. PMID: 15067027
201 results